U.S. Financially Fit Penny Stocks

Kopin

Market Cap: US$407.1m

Develops, manufactures, and sells microdisplays, subassemblies, and related components for defense, enterprise, industrial, and consumer products in the United States, the Asia-Pacific, Europe, and internationally.

Metagenomi

Market Cap: US$81.8m

A genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States.

Vaso

Market Cap: US$21.1m

Operates in the healthcare equipment and information technology industries in the United States and internationally.

Rallybio

Market Cap: US$24.5m

A clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.

Hyliion Holdings

Market Cap: US$375.4m

Designs and develops power generators for stationary and mobile applications.

Etrion

Market Cap: US$100.2k

Does not have significant operations.

Blend Labs

Market Cap: US$1.0b

Provides a cloud-based software platform for financial services firms in the United States.

Destiny Media Technologies

Market Cap: US$4.0m

Develops technologies that enable the distribution of digital media files in a streaming or digital download format over the Internet.

Genelux

Market Cap: US$162.1m

A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.

Escalon Medical

Market Cap: US$1.9m

Engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally.

Neumora Therapeutics

Market Cap: US$309.3m

A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.

Virax Biolabs Group

Market Cap: US$2.8m

A biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics.

IZEA Worldwide

Market Cap: US$64.6m

Provides software and professional services to connect brands and content creators in North America, the Asia Pacific, and internationally.

UC Asset

Market Cap: US$5.5m

A limited partnership, invests in real estate for development and redevelopment in the Atlanta area.

Franklin Wireless

Market Cap: US$47.1m

Provides integrated wireless solutions in North America and Asia.

Cumberland Pharmaceuticals

Market Cap: US$44.6m

A specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally.

Pliant Therapeutics

Market Cap: US$89.6m

A biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases.

Lisata Therapeutics

Market Cap: US$20.1m

A clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.

TrueCar

Market Cap: US$198.1m

Operates as an internet-based information, technology, and communication services company in the United States.

AsiaFIN Holdings

Market Cap: US$63.1m

An investment holding company, primarily engages in the provision of market research studies and consultancy services to the payment solution industry in ASEAN countries, and internationally.

Cato

Market Cap: US$82.4m

Operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States.

Relmada Therapeutics

Market Cap: US$55.4m

Operates as a clinical-stage biotechnology company in the United States.

AN2 Therapeutics

Market Cap: US$35.3m

A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.

TDH Holdings

Market Cap: US$11.4m

Engages in the commercial real estate management business in the United States.

Caribou Biosciences

Market Cap: US$173.2m

A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.

Atea Pharmaceuticals

Market Cap: US$230.1m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

Nuvation Bio

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

Dixie Group

Market Cap: US$10.6m

Manufactures, markets, and sells floorcovering products to residential customers in North America and internationally.

Veru

Market Cap: US$49.4m

A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).

Zenvia

Market Cap: US$69.1m

Develops a cloud-based platform that enables organizations to integrate various communication capabilities in Brazil, the United States, Argentina, Mexico, the Netherlands, Malta, Peru, Switzerland, Colombia, Chile, and internationally.

Silver Bull Resources

Market Cap: US$12.8m

An exploration stage company, acquires, explores, and develops mineral properties in Mexico.

Kentucky First Federal Bancorp

Market Cap: US$31.0m

Operates as the holding company for First Federal Savings and Loan Association of Hazard, Kentucky, and Frankfort First Bancorp, Inc.

Tilly's

Market Cap: US$60.6m

Operates as a specialty retailer of casual apparel, footwear, accessories, and hardgoods for young men and women, boys, and girls in the United States.

BT Brands

Market Cap: US$10.2m

Owns and operates fast-food restaurants in the north central region of United States.

Zedge

Market Cap: US$41.4m

Zedge, Inc. builds digital marketplaces and competitive games around content that people use to express themselves.

Alto Ingredients

Market Cap: US$85.1m

Produces, distributes, and markets specialty alcohols, renewable fuel, and essential ingredients in the United States.